|
C2 / d10 concomitant products grid - added
d1 catalog# and product long description ¿ updated
d2 product code ¿ corrected
d2 common device name - corrected
d3/g1 manufacturing facility - corrected
d4 lot # - updated
d4 expiration date ¿ added
d4 gtin ¿ added
g4 ¿ pma/510(k) ¿ corrected
h4 manufacturing date ¿ added
fda reg # incorrectly entered as 3008881809.Should be 3012931345.Due to the automated mes (manufacturing execution system) system there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, visual and functional testing as well as physical analysis cannot be performed.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.It was reported that ¿the 52 yrs female, with past history of hypertension, had a right internal carotid artery-ophthalmic (c6 segment) saccular aneurysm (5.52x2.98x4.33mm, neck 3.16mm) with no parent artery stenosis.Severe in-stent stenosis of the cavernous segment of the right internal carotid artery, performed balloon angioplasty + stent implantation.Performed balloon angioplasty and stent implantation for stenosis of the cavernous segment of the right internal carotid artery under general.Outcome of ae: resolved.Is the ae related to the investigational device: probable¿.Additional information provided by the customer indicated the ae was related to other non-investigational stryker devices: axs catalyst 5, synchro standard, excelsior xt-27.Based upon medical review, the harm observed in this complaint is anticipated in nature as per the device risk assessment.As a product related root cause does not apply and the issue is due to a known physiological effect of the procedure and/or patient condition noted within the dfu, product labeling and/or risk documentation files, an assignable cause of anticipated procedural complication will be assigned to the reported event of patient parent vessel stenosis.
|